You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

"HIV treatment is lifesaving but also lifelong," said Patrick Jackson, MD, one of the two lead authors on the paper. "Understanding how the virus stays latent in cells could help us develop a lasting ...

Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...

University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure, bringing researchers closer to finding ways to flush out the dormant virus and ...

Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...

A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...

The HIV/AIDS epidemic spiked in the 1980s, resulting in the death of over 100,000 people from 1981 to 1990, making an irreversible mark on our world from a social, medical, and political perspective.